Aptus Pharma Ltd vs Tyche Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Aptus Pharma Ltd is ₹ 405 as of 30 Apr 15:30 . The P/E Ratio of Aptus Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tyche Industries Ltd changed from 8.7 on March 2021 to 11 on March 2025 . This represents a CAGR of 4.80% over 5 years The Market Cap of Aptus Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tyche Industries Ltd changed from ₹ 174.66 crore on March 2021 to ₹ 136.38 crore on March 2025 . This represents a CAGR of -4.83% over 5 years The revenue of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tyche Industries Ltd for the Dec '25 is ₹ 12.43 crore as compare to the Sep '25 revenue of ₹ 16.81 crore. This represent the decline of -26.06% The ebitda of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tyche Industries Ltd for the Dec '25 is ₹ 2.94 crore as compare to the Sep '25 ebitda of ₹ 2.52 crore. This represent the growth of 16.67% The net profit of Aptus Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Tyche Industries Ltd changed from ₹ 2.73 crore to ₹ 1.82 crore over 7 quarters. This represents a CAGR of -20.68% The Dividend Payout of Aptus Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tyche Industries Ltd changed from 5.13 % on March 2021 to 24.78 % on March 2025 . This represents a CAGR of 37.02% over 5 years .

About Aptus Pharma Ltd

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

About Tyche Industries Ltd

Tyche Industries Limited (formerly known as Siris Soft Limited) was incorporated on Jul' 23, 1998.
TIL is one of the largest manufacturers in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe.
Company's operations are predominantly related to the manufacture of bulk drugs intermediates. The company has established two advanced development centers in the area of e-commerce in New Jersey, USA and Hyderabad.
The company has three business models namely offshore solutions, offsite solutions and onsite solutions.
It has entered into strategic alliance with Allegheny Digital Corp, Organic Online Inc, Transaction Information System Inc, CMC and Business Software Solutions Inc. The company is coming with a public issue of 26 lac equity shares of Rs.

FAQs for the comparison of Aptus Pharma Ltd and Tyche Industries Ltd

Which company has a larger market capitalization, Aptus Pharma Ltd or Tyche Industries Ltd?

Market cap of Aptus Pharma Ltd is 277 Cr while Market cap of Tyche Industries Ltd is 125 Cr

What are the key factors driving the stock performance of Aptus Pharma Ltd and Tyche Industries Ltd?

The stock performance of Aptus Pharma Ltd and Tyche Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aptus Pharma Ltd and Tyche Industries Ltd?

As of May 4, 2026, the Aptus Pharma Ltd stock price is INR ₹405.0. On the other hand, Tyche Industries Ltd stock price is INR ₹122.92.

How do dividend payouts of Aptus Pharma Ltd and Tyche Industries Ltd compare?

To compare the dividend payouts of Aptus Pharma Ltd and Tyche Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.